Stay updated on Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T10:05:10.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with a revision update from v2.16.0 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-30T04:52:00.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.3%
    Check dated 2025-05-23T02:13:59.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:19:53.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.15.0) and the addition of the study identifier 2125-RST-101, while significant details about the Phase 1b study and its inclusion and exclusion criteria have been removed.
    Difference
    33%
    Check dated 2025-04-16T20:26:57.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T13:48:46.000Z thumbnail image

Stay in the know with updates to Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page.